Skip to main content
  • 388 Accesses

Abstract

The designation “brain tumor” is commonly applied to a wide variety of intracranial mass lesions, each distinct in location, biology, treatment, and prognosis. Since many of these lesions do not arise from brain parenchyma, the more appropriate term is “intracranial tumor”. Since the category encompasses both neoplasms and non-neoplastic mass lesions, the word “tumor” is used in its broadest sense to indicate a space-occupying mass.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Atlas SW, Lavi E, Fisher PG (2002) Intraaxial brain tumors. In: Atlas SW (ed) Magnetic resonance imaging of the brain and spine. Lippincott Williams Wilkins, Philadelphia, pp 565–693

    Google Scholar 

  2. Altas SW, Lavi E, Golberg HI (2002) Extraaxial brain rumors. In: Atlas SW (ed) Magnetic resonance imaging of the brain and spine. Lippincott Williams Wilkins, Philadelphia, pp 695–772

    Google Scholar 

  3. Grossman RI, Yousem DM (2003) Neoplasms of the brain. In: Thrall JH (ed) Neuroradiology: the requisites. Mosby Elsevier, Philadelphia, pp 97-172

    Google Scholar 

  4. Osborn AG, Rauschning W (1994) Brain tumors and tumorlike masses: classification and differential diagnosis. In: Patterson AS (ed) Diagnostic neuroradiology. Mosby Year Book, St. Louis, pp 401–528

    Google Scholar 

  5. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114–123

    Article  PubMed  CAS  Google Scholar 

  6. Zamani AA (2000) Cerebellopontine angle tumors: role of magnetic resonance imaging. Top Magn Reson Imaging 11:98–107

    Article  PubMed  CAS  Google Scholar 

  7. Luh GY, Bird CR (1999) Imaging of brain tumors in the pediatric population. Neuroimaging Clin N Am 9:691–716

    PubMed  CAS  Google Scholar 

  8. Koeller KK, Smirniotopoulos JG, Jones RV (1997) Primary central nervous system lymphoma: radiologie-pathologie correlation. Radiographies 17:1497–1526

    CAS  Google Scholar 

  9. Lassman AB, DeAngelis LM (2003) Brain metastases. Neurol Clin 21:1–23

    Article  PubMed  Google Scholar 

  10. Kauppinen RA (2002) Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed 15:6–17

    Article  PubMed  CAS  Google Scholar 

  11. Castillo M, Mukherji SK (2000) Diffusion-weighted imaging in the evaluation of intracranial lesions. Semin Ultrasound CT MR 21:405–416

    Article  PubMed  CAS  Google Scholar 

  12. Le Bihan D, Douek P, Argyropoulou M, Turner R, Patronas N, Fulham M (1993) Diffusion and perfusion magnetic resonance imaging in brain tumors. Top Magn Reson Imaging 5:25–31

    Article  PubMed  Google Scholar 

  13. Chenevert TL, Meyer CR, Moffat BA, Rehemtulla A, Mukherji SK, Gebarski SS, Quint DJ, Robertson PL, Lawrence TS, Junck L, Taylor JM, Johnson TD, Dong Q, Muraszko KM, Brunberg JA, Ross BD (2002) Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 1:336–343

    Article  PubMed  Google Scholar 

  14. Aronen H, Glass J, Pardo F, Belliveau J, Gruber M (1995) Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. Acta Radiologica 86:520–528

    Google Scholar 

  15. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II (1999) Dynamic contrast-enhanced T2*-weighted MR imaging of glial neoplasms. Radiology 211:791–798

    PubMed  CAS  Google Scholar 

  16. Cha S, Knopp EA, Johnson G et al (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11–29

    Article  PubMed  Google Scholar 

  17. Cha S, Knopp EA, Johnson G et al (2000) Dynamic, contrastenhanced T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 21:881–890

    PubMed  CAS  Google Scholar 

  18. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary métastases: differentiation using perfusion MR imaging and proton spectroscopic MR imaging. Radiology 222:715–721

    Article  PubMed  Google Scholar 

  19. Norfray JF, Darling C, Byrd S, Ross B et al (1999) Short TE proton MRS and neurofibromatosis type 1 intracranial tumors. J Comp Assist Tomogr 23(6):994–1003

    Article  CAS  Google Scholar 

  20. Zimmerman R et al (1994) CHOP, Philadelphia 3

    Google Scholar 

  21. Nelson SJ, McKnight TR, Henry RG (2002) Characterization of untreated gliomas by magnetic resonance spectroscopic imaging. Neuroimaging Clin N Am 12:599–613

    Article  PubMed  Google Scholar 

  22. Poussaint TY (2001) Magnetic resonance imaging of pediatric brain tumors: state of the art. Top Magn Reson Imaging 12:411–433

    Article  PubMed  CAS  Google Scholar 

  23. Earnest F 4th, Kelly PJ, Scheithauer BW, Kall BA, Cascino TL, Ehman RL, Forbes GS, Axley PL, Earnest F (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823–827

    PubMed  Google Scholar 

  24. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB (1987) Stereotactic histologie correlations of computed tomography-and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62:450–459

    Article  PubMed  CAS  Google Scholar 

  25. Schiffer D (2000) Glioma malignancy and its biological and histological correlates. J Neurosurg Sci 34:163–165

    Google Scholar 

  26. Schiffer D (1991) Pathology of brain tumors and its clinicobiological correlates. Dev Oncol 66:3–9

    Google Scholar 

  27. Kleinman G, Zagzag D, Miller D (1994) Diagnostic use of immunohistochemistry in neuropathology. Neurosurg Clin N Am 5:97–126

    PubMed  CAS  Google Scholar 

  28. Fine HA (1995) Novel biologic therapies for malignant gliomas. Antiangiogenesis, immunotherapy, and gene therapy. Neurol Clin 13:827–846

    PubMed  CAS  Google Scholar 

  29. Sheporaitis LA, Osborn AG, Smirniotopoulos JG et al (1992) Intracranial meningioma. AJNR Am J Neuroradiol 13:29–37

    PubMed  CAS  Google Scholar 

  30. Maiuri F, Iaconetta G, de Divitiis O et al (1999) Intracranial meningiomas: correlations between MR imaging and histology. Eur J Radiol 31:69–75

    Article  PubMed  CAS  Google Scholar 

  31. Fitzpatrick M, Tartaglino LM, Hollander MD et al (1999) Imaging of sellar and parasellar pathology. Radiol Clin North Am 37:101–121

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Italia

About this chapter

Cite this chapter

Knopp, E.A., Montanera, W. (2004). Brain Tumors. In: von Schulthess, G.K., Zollikofer, C.L. (eds) Diseases of the Brain, Head and Neck, Spine. Springer, Milano. https://doi.org/10.1007/978-88-470-2131-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2131-0_1

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0251-7

  • Online ISBN: 978-88-470-2131-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics